1![April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:](https://www.pdfsearch.io/img/da11fdbdc24b5be725c7dbd4c93327a6.jpg) | Add to Reading ListSource URL: www.dcat.orgLanguage: English - Date: 2016-04-07 10:30:28
|
---|
2![benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b](https://www.pdfsearch.io/img/4b442ee37f0d1c22c79849e3c545a25f.jpg) | Add to Reading ListSource URL: milfordk12.orgLanguage: English |
---|
3![May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese](https://www.pdfsearch.io/img/811166e64d4feefca5cd01fa0ce79090.jpg) | Add to Reading ListSource URL: www.dcat.orgLanguage: English - Date: 2016-05-13 09:47:23
|
---|
4![Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich](https://www.pdfsearch.io/img/187438b4bcc727bef7a5599d29357386.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-05-30 21:34:45
|
---|
5![For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University, For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University,](https://www.pdfsearch.io/img/3fcc102c3fe5b82e755420cff8364c0f.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-04-14 01:21:57
|
---|
6![For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie](https://www.pdfsearch.io/img/4c35d4969f5ab886c238616bcb0096e2.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-04-18 01:10:20
|
---|
7![For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries](https://www.pdfsearch.io/img/8b0de0cfa89010e9834dae8705c7a5e9.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-05-11 04:43:58
|
---|
8![For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie](https://www.pdfsearch.io/img/c7543b4e42d88302bd0ae32390839d41.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-05-11 06:06:42
|
---|
9![For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie](https://www.pdfsearch.io/img/23d79452ab5d72630fa88b0c8ad340f7.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-05-24 20:52:07
|
---|
10![Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation](https://www.pdfsearch.io/img/b96982fe356811090f0fce25155dbb71.jpg) | Add to Reading ListSource URL: www.daiichisankyo.comLanguage: English - Date: 2016-05-20 07:19:52
|
---|